Enrico C Nista

Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

50 publications 2006 – 2026

What does Enrico C Nista research?

Dr. Nista studies conditions that affect the pancreas, such as pancreatic cancer, pancreatitis, and diabetes that arises from pancreatic issues. His research explores how the gut microbiota, which are the billions of microorganisms living in our intestines, can influence these conditions and their treatments. He investigates advanced treatments like insulin pumps for managing diabetes, and how certain diets and probiotics (beneficial bacteria) might help improve gut health and manage digestive issues. By understanding these complex interactions, Dr. Nista aims to provide new solutions and improve patient outcomes for those suffering from serious digestive and pancreatic conditions.

Key findings

  • In a case study, a hybrid closed-loop insulin pump improved a patient's blood sugar control, increasing his time in the target range from 43% to 88% over three months.
  • Research found that diabetes prevalence in patients with chronic pancreatitis was 56%, compared to 33% in those without the condition.
  • His review highlighted connections between gut microbiota and pancreatic cancer, indicating potential therapeutic approaches using engineered microbes.
  • The study on antibiotic use in acute pancreatitis revealed that although antibiotics can prevent infections, routine use is often discouraged due to risks like antibiotic resistance.
  • New potential biomarkers for early detection of pancreatic cancer were identified, which could significantly improve diagnosis and treatment outcomes.

Frequently asked questions

Does Dr. Nista study pancreatic cancer?
Yes, Dr. Nista conducts research on pancreatic cancer, particularly its links to gut microbiota and potential new treatments.
What is Small Intestinal Bacterial Overgrowth (SIBO) and how is Dr. Nista involved?
SIBO is a condition where excessive bacteria grow in the small intestine, leading to digestive issues. Dr. Nista reviews its diagnosis and treatment methods to improve gut health for affected patients.
What treatments has Dr. Nista researched for pancreatitis?
He has explored the role of gut microbiota and probiotics in managing acute pancreatitis and has reviewed the use of antibiotics and their implications in treatment.
Is Dr. Nista's work relevant to patients with diabetes?
Absolutely, he has researched diabetes resulting from pancreatic issues and studied advanced insulin delivery methods to improve blood sugar management.
How can gut health affect pancreatic diseases according to Dr. Nista's research?
His research indicates that an imbalance in gut bacteria can influence the severity of pancreatic diseases and the effectiveness of treatments, thus improving gut health may lead to better management of these conditions.

Publications in plain English

Clinical outcomes of hypertriglyceridemia-associated acute pancreatitis: a prospective multicenter Italian cohort.

2026

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

De Marchi G, de Pretis N, Capurso G, Pezzilli R, Zambon A +19 more

PubMed

Unraveling the Complexities of Small Intestinal Bacterial Overgrowth.

2026

Medicina (Kaunas, Lithuania)

Capuano E, Del Gaudio A, Nista EC, De Lucia SS, Pellegrino A +4 more

Plain English
This research paper looks at Small Intestinal Bacterial Overgrowth (SIBO), a condition where too many bacteria grow in the small intestine. It reviews how SIBO relates to other digestive problems, the ways doctors can diagnose it, and the different treatments available, such as antibiotics and diet changes. Understanding SIBO is important because it can lead to better gut health and more effective treatment for those affected. Who this helps: Patients suffering from digestive issues caused by SIBO.

PubMed

A single bout of physical exercise improves 1-hour post-load plasma glucose in healthy young adults.

2025

Journal of endocrinological investigation

Moffa S, Sorice GP, Di Giuseppe G, Cinti F, Ciccarelli G +8 more

Plain English
This study looked at how a single session of aerobic exercise affects blood sugar levels and insulin response in healthy young adults. Researchers found that after a 30-minute workout, participants had 28% lower blood sugar levels one hour after consuming glucose and showed improved insulin sensitivity. These findings are important because they highlight how even short exercises can help regulate blood sugar and improve metabolic health. Who this helps: This benefits individuals looking to maintain healthy blood sugar levels, such as young adults and those at risk of diabetes.

PubMed

Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1.

2025

Metabolism: clinical and experimental

Mezza T, Wewer Albrechtsen NJ, Di Giuseppe G, Ferraro PM, Soldovieri L +11 more

Plain English
This study looked at the function of certain cells in the pancreas and their connection to blood sugar control in 61 people having surgery for a non-cancerous growth. The researchers found that participants with poorer blood sugar tolerance and early diabetes had higher levels of intact GLP-1—specifically, they measured 1.15 pmol/g of intact GLP-1 in those with impaired glucose tolerance and diabetes. This matters because it suggests that higher levels of this hormone might be the body's way to help regulate insulin when blood sugar control is already compromised. Who this helps: This information benefits patients with impaired glucose tolerance and diabetes by providing insights into their condition.

PubMed

In humans increase in intrapancreatic adipose tissue predicts beta-cell dedifferentiation score before diabetes onset: A pilot study.

2025

Diabetes research and clinical practice

Cinti F, Mezza T, Severi I, Moffa S, Giuseppe GD +17 more

Plain English
This study looked at how fat in the pancreas might influence the health of insulin-producing cells in people at risk of diabetes. Researchers found that patients with newly diagnosed diabetes had a much higher amount of pancreatic fat (about 44%) compared to those with normal glucose levels (about 4%), and that as fat increased, the health of the insulin-producing cells worsened. This information is important because it suggests that reducing pancreatic fat could be a new way to prevent diabetes from developing. Who this helps: This helps patients at risk for diabetes and healthcare professionals managing their care.

PubMed

Exploring nutraceutical approaches linking metabolic syndrome and cognitive impairment.

2025

iScience

Sonnino R, Ciccarelli G, Moffa S, Soldovieri L, Di Giuseppe G +8 more

Plain English
This study looked at how certain dietary supplements, called nutraceuticals, might help people with metabolic syndrome and mild cognitive impairment, which are conditions that can influence each other due to shared health issues like inflammation. The research reviewed evidence showing that these supplements could potentially reduce problems caused by both conditions and improve overall health. Since improving these conditions is important for preventing more serious health issues, finding effective nutraceuticals could be a helpful addition to lifestyle changes like diet and exercise. Who this helps: This helps patients with metabolic syndrome and mild cognitive impairment.

PubMed

Investigating Immune Checkpoint Inhibitor-Induced Pancreatic Injury: When to Discontinue Cancer Therapy.

2025

Metabolites

Nista EC, De Lucia SS, Archilei S, Iaccarino J, Piccirilli G +4 more

Plain English
This research examined how cancer treatments using immune checkpoint inhibitors (ICIs) can sometimes cause damage to the pancreas. It found that while minor increases in certain enzyme levels (amylase and lipase) in the blood usually do not mean there is a serious problem, doctors often still check for them unnecessarily, which can lead to confusion and disruptions in treatment. The study highlights the need for clear guidelines to help doctors manage these potential issues more effectively, ensuring that patients can continue their cancer therapy without unnecessary interruptions. Who this helps: This benefits cancer patients receiving immune checkpoint inhibitor treatments and their doctors.

PubMed

Corrigendum to "In humans increase in intrapancreatic adipose tissue predicts beta-cell dedifferentiation score before diabetes onset: A pilot study" [Diabetes Res. Clin. Pr. 221 (2025) MS N. 112029].

2025

Diabetes research and clinical practice

Cinti F, Mezza T, Severi I, Moffa S, Giuseppe GD +17 more

PubMed

Altered GIP/GLP-1 Secretion Ratio is Associated With Impaired β Cell Function in Humans.

2025

The Journal of clinical endocrinology and metabolism

Di Giuseppe G, Gliozzo G, Ciccarelli G, Carciero L, Brunetti M +13 more

Plain English
This study looked at how two hormones, GIP and GLP-1, which help control blood sugar, are produced in people with different levels of glucose tolerance: normal, impaired, and diabetes. The researchers found that while the overall levels of both hormones were similar among the groups, the ratio of GIP to GLP-1 was lower in people with diabetes compared to those with normal or impaired glucose tolerance. This imbalance could indicate early signs of problems with insulin-producing cells in the pancreas, which is important for understanding diabetes progression. Who this helps: This helps patients at risk of developing type 2 diabetes and their doctors by identifying early warning signs of pancreatic dysfunction.

PubMed

Incretin system and glucagon secretion in patients with chronic pancreatitis.

2025

European journal of clinical investigation

Ciccarelli G, Di Giuseppe G, Gliozzo G, Soldovieri L, Quero G +12 more

Plain English
This study looked at how chronic pancreatitis affects hormone levels and diabetes, specifically focusing on hormones that regulate blood sugar. Researchers tested 32 patients with chronic pancreatitis and 60 without it, and found that diabetes was more common in those with chronic pancreatitis (56% compared to 33%). They discovered that problems with hormone secretion were linked to blood sugar control, but these issues were similar regardless of whether patients had chronic pancreatitis. Who this helps: This research benefits patients with chronic pancreatitis and diabetes, as well as doctors treating them.

PubMed

Corrigendum to "Human subjects with impaired beta-cell function and glucose tolerance have higher levels of intra-islet intact GLP-1" [Metabolism, Volume 163 (2025), Article Number 156087].

2025

Metabolism: clinical and experimental

Mezza T, Wewer Albrechtsen NJ, Di Giuseppe G, Ferraro PM, Soldovieri L +11 more

PubMed

Exploring the Role of Gut Microbiota and Probiotics in Acute Pancreatitis: A Comprehensive Review.

2025

International journal of molecular sciences

Nista EC, Parello S, Brigida M, Amadei G, Saviano A +4 more

Plain English
This study looked at how gut bacteria and probiotics (beneficial microorganisms) relate to acute pancreatitis, a serious condition where the pancreas becomes inflamed. Researchers found that the makeup of gut bacteria influences how the body responds to inflammation during an acute pancreatitis attack, suggesting that changing this bacterial balance could help reduce symptoms and improve recovery. This is important because targeted treatments like probiotics could help patients have fewer complications from this painful condition. Who this helps: Patients with acute pancreatitis.

PubMed

Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components.

2025

Cancers

De Lucia SS, Nista EC, Candelli M, Archilei S, Deutschbein F +4 more

Plain English
This research focused on pancreatic cancer, a very deadly type of cancer called pancreatic ductal adenocarcinoma (PDAC), which has not seen much improvement in survival rates for years. The study found that the microbiome—the collection of microorganisms in our bodies—plays a significant role in how this cancer starts and responds to treatments. Approaches like using engineered bacteria or probiotics could lead to new and better treatments for patients, making care more effective. Who this helps: This helps pancreatic cancer patients and doctors looking for improved treatment options.

PubMed

Use of hybrid closed-loop insulin pump in pancreatogenic diabetes following necrotizing hemorrhagic pancreatitis: a case report.

2025

Frontiers in clinical diabetes and healthcare

Soldovieri L, Ciccarelli G, Brunetti M, Di Giuseppe G, Gentile E +6 more

Plain English
This study focused on a 60-year-old man who developed diabetes after suffering severe pancreatitis. After struggling with high blood sugar levels and ineffective oral medications, he started using a hybrid closed-loop insulin pump, which dramatically improved his blood sugar control; his time in the target range for blood sugar increased from 43% to 88% in three months, and his average glucose level dropped from 7.9% to 6.5%. This is important because it shows that advanced insulin delivery technology can better manage diabetes that arises from pancreas issues, providing a solution for patients who don't respond well to traditional treatments. Who this helps: This helps patients with pancreatogenic diabetes and their doctors by offering a more effective way to manage their blood sugar levels.

PubMed

Reduced incretin effect precedes diabetes development following duodenopancreatectomy in individuals without diabetes.

2024

The Journal of clinical investigation

Di Giuseppe G, Soldovieri L, Ciccarelli G, Ferraro PM, Quero G +12 more

PubMed

Neuropancreatology: The Nervous System and Pain Management in Pancreatic Diseases.

2024

Life (Basel, Switzerland)

Nicoletti A, Vitale F, Paratore M, Quero G, Negri M +4 more

Plain English
This research paper examines how the nervous system connects to pancreatic diseases and the pain they cause. It highlights that changes in the pancreatic nervous system can lead to increased pain and complications, especially in conditions like pancreatic cancer. The paper emphasizes the need for personalized pain management approaches, as standard treatments often do not fully address patients’ needs. Who this helps: This benefits patients suffering from pancreatic diseases and their doctors looking for better pain management strategies.

PubMed

Beta-cell function and glucose metabolism in patients with chronic pancreatitis.

2024

European journal of internal medicine

Ciccarelli G, Di Giuseppe G, Soldovieri L, Quero G, Nista EC +11 more

Plain English
This study looked at how well the pancreas, specifically the cells that produce insulin, works in patients with chronic pancreatitis (CP) compared to those without it. The researchers tested 146 people and found that while patients with CP generally produce less insulin, when they were grouped by their overall glucose tolerance (normal, impaired, or diabetic), there were no significant differences in insulin function or sensitivity. However, they discovered that those with both CP and diabetes had lower insulin production in response to arginine, indicating a specific issue with insulin secretion linked to diabetes. Who this helps: This research helps patients with chronic pancreatitis and diabetes by highlighting the specific challenges they face regarding insulin production.

PubMed

Advancing Diabetes Research: A Novel Islet Isolation Method from Living Donors.

2024

International journal of molecular sciences

Di Piazza E, Todi L, Di Giuseppe G, Soldovieri L, Ciccarelli G +10 more

Plain English
Researchers studied a new method for isolating pancreatic islets, which are crucial for understanding type 2 diabetes. They found that using a simplified technique on small tissue samples from living donors improved the quality and functionality of the isolated islets. Notably, they observed that insulin secretion decreased in diabetic islets, while proinsulin secretion increased, helping to reflect the donors' health conditions. Who this helps: This benefits researchers and patients with diabetes by advancing studies and potential treatments.

PubMed

The interplay of extracellular vesicles in the pathogenesis of metabolic impairment and type 2 diabetes.

2024

Diabetes research and clinical practice

Carciero L, Di Giuseppe G, Di Piazza E, Parand E, Soldovieri L +8 more

Plain English
This research paper looks at how tiny particles called extracellular vesicles (EVs) play a role in the development of type 2 diabetes (T2D) by helping different organs communicate with each other. The study found that these EVs contain important molecules that impact how the body processes insulin and sugar, which may help in identifying T2D earlier and finding new treatment options. Understanding EVs could lead to better ways to diagnose and manage T2D, benefiting both patients and healthcare providers. Who this helps: Patients with type 2 diabetes and their doctors.

PubMed

A single-center prospective analysis of the impact of glucose metabolism on pancreatic fistula onset after pancreaticoduodenectomy for periampullary tumors.

2024

American journal of surgery

Quero G, Laterza V, Di Giuseppe G, Lucinato C, Massimiani G +17 more

Plain English
This study looked at how glucose metabolism affects the development of pancreatic fistulas in patients undergoing surgery for tumors near the pancreas. Researchers examined 110 patients and found that 36.3% developed these fistulas, with those who had normal glucose levels experiencing the highest rate at 51.7%. The study found that lower fasting glucose levels and higher c-peptide levels were significant indicators of fistula development, making these measurements useful for predicting who may be at risk after surgery. Who this helps: This helps doctors identify which patients are at higher risk for complications after pancreatic surgery.

PubMed

The Past, Present, and Future of Biomarkers for the Early Diagnosis of Pancreatic Cancer.

2024

Biomedicines

Vitale F, Zileri Dal Verme L, Paratore M, Negri M, Nista EC +9 more

Plain English
This paper looks at the ongoing research into early detection methods for pancreatic cancer, which is a deadly disease with a low survival rate. The most commonly used biomarker, CA 19-9, has limitations and isn't effective for screening. Researchers have identified several new potential biomarkers from various body fluids, but more extensive studies are needed to confirm their usefulness. Advancements in technologies are also helping improve the search for effective diagnostic tools. Who this helps: This benefits patients by aiming to detect pancreatic cancer earlier, increasing their chances for successful treatment.

PubMed

The Role of the Gastrointestinal Microbiota in Parkinson's Disease.

2024

Biomolecules

Gabrielli M, Zileri Dal Verme L, Zocco MA, Nista EC, Ojetti V +1 more

Plain English
This research paper studied how changes in gut bacteria (the gastrointestinal microbiota) might affect Parkinson's disease (PD). It found that an imbalance in gut bacteria is linked to worse symptoms of PD, including increased inflammation and nerve damage. This is important because improving gut health might help manage the disease better, particularly in how well treatments like L-dopa work. Who this helps: This helps patients with Parkinson's disease.

PubMed

Endoscopic pancreatic sphincterotomy in patients with IPMN-related recurrent pancreatitis: A single center experience.

2023

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Schepis T, Tringali A, D'aversa F, Perri V, Familiari P +3 more

Plain English
This study looked at how a procedure called endoscopic pancreatic sphincterotomy (EPS) can help patients with a rare type of pancreatitis linked to pancreatic tumors known as IPMN. The researchers followed 25 patients who underwent the procedure for an average of nearly 8 years, finding that the average number of acute pancreatitis episodes dropped significantly from about 3.3 episodes per year before the procedure to just 0.5 afterward. This is important because it shows that EPS is a safe and effective way to reduce painful pancreatitis episodes in these patients. Who this helps: This benefits patients with IPMN-related pancreatitis.

PubMed

Diagnostic and Prognostic Role of Extracellular Vesicles in Pancreatic Cancer: Current Evidence and Future Perspectives.

2023

International journal of molecular sciences

Nicoletti A, Negri M, Paratore M, Vitale F, Ainora ME +4 more

Plain English
This study looked at extracellular vesicles, which are tiny particles released by cells, to see how they can help diagnose and predict pancreatic cancer. It found that these vesicles are important in how the cancer progresses and how it resists treatment, highlighting their potential as useful biomarkers for early detection. Finding better ways to identify pancreatic cancer early is crucial because current detection methods are not effective, leading to lower survival rates. Who this helps: This research benefits patients with pancreatic cancer and their doctors by improving early diagnosis and treatment options.

PubMed

Pancreatic Cancer Resistance to Treatment: The Role of Microbiota.

2023

Biomedicines

Nista EC, Del Gaudio A, Del Vecchio LE, Mezza T, Pignataro G +4 more

Plain English
This study looked at how bacteria in the body may influence the resistance of pancreatic cancer to treatments. Researchers found that certain types of bacteria are linked to how well patients respond to therapies, suggesting that the presence of these microbes can affect treatment outcomes. Understanding these interactions could help improve survival rates for people with pancreatic cancer. Who this helps: This helps patients with pancreatic cancer and their doctors by highlighting potential new ways to enhance treatment effectiveness.

PubMed

First-phase insulin secretion: can its evaluation direct therapeutic approaches?

2023

Trends in endocrinology and metabolism: TEM

Di Giuseppe G, Ciccarelli G, Soldovieri L, Capece U, Cefalo CMA +8 more

Plain English
This study looked at how the first-phase insulin secretion works in people with type 2 diabetes and how it’s connected to insulin resistance and the function of insulin-producing cells. The researchers emphasized that when insulin secretion is impaired, it can lead to high blood sugar levels after meals, which is a key issue in managing diabetes. They explored ways to improve insulin secretion through diet and medication, and they also considered how doctors can spot these early defects in insulin release. Who this helps: This benefits patients with type 2 diabetes and their doctors by improving diabetes management strategies.

PubMed

Nutrition in Acute Pancreatitis: From the Old Paradigm to the New Evidence.

2023

Nutrients

De Lucia SS, Candelli M, Polito G, Maresca R, Mezza T +7 more

Plain English
This research paper looks at how nutrition is managed in patients with acute pancreatitis, highlighting a shift from an older method that involved resting the pancreas, to a newer approach that encourages early oral or tube feeding. The findings show that early feeding can lead to better outcomes, including a 30% lower risk of multiple-organ failure and reduced mortality rates. This is important because it suggests that changing how we feed patients could directly improve their chances of recovery. Who this helps: This helps patients recovering from acute pancreatitis.

PubMed

An update on pancreatic regeneration mechanisms: Searching for paths to a cure for type 2 diabetes.

2023

Molecular metabolism

Soldovieri L, Di Giuseppe G, Ciccarelli G, Quero G, Cinti F +7 more

Plain English
This research looks at how the pancreas can heal itself and produce more insulin-producing cells, which is important for treating type 2 diabetes. The study found that understanding the signals that help the pancreas regenerate could lead to new treatments, but specific numbers were not provided. This is important because finding ways to increase the number of insulin-producing cells could help manage or even cure diabetes. Who this helps: This helps patients with type 2 diabetes.

PubMed

Physical Activity and Type 2 Diabetes: In Search of a Personalized Approach to Improving β-Cell Function.

2023

Nutrients

Di Murro E, Di Giuseppe G, Soldovieri L, Moffa S, Improta I +9 more

Plain English
This study looked at how different types and amounts of physical activity affect blood sugar control and a key part of the pancreas called the β-cell in people with or at risk for Type 2 diabetes. It highlighted that exercise can impact blood sugar differently for each person, making personalized exercise plans important. The research found that tailoring exercise routines could help improve blood sugar levels, but it didn't provide specific numbers. Who this helps: This benefits patients with Type 2 diabetes and prediabetes by offering more effective exercise strategies tailored to their needs.

PubMed

Effects of functional foods, nutraceuticals, and herbal products on pancreas.

2023

Chinese medical journal

Saviano A, Zanza C, Longhitano Y, Nista EC, Franceschi F +1 more

PubMed

State-of-the-Art and Upcoming Innovations in Pancreatic Cancer Care: A Step Forward to Precision Medicine.

2023

Cancers

Schepis T, De Lucia SS, Pellegrino A, Del Gaudio A, Maresca R +6 more

Plain English
This study looked at the current state and future developments in treating pancreatic cancer, a type of cancer that is difficult to diagnose early and has high death rates. Researchers found that while surgery is the only way to potentially cure pancreatic cancer, most patients are diagnosed too late for this option. Improvements in surgical techniques and other therapies have made treatment safer and more effective, but a personalized approach is crucial for each patient to determine the best treatment plan. Who this helps: This helps patients with pancreatic cancer and their doctors by providing better treatment options and strategies.

PubMed

Antibiotic Utilization in Acute Pancreatitis: A Narrative Review.

2023

Antibiotics (Basel, Switzerland)

Severino A, Varca S, Airola C, Mezza T, Gasbarrini A +3 more

Plain English
Researchers reviewed how antibiotics are used in treating acute pancreatitis, a serious inflammatory condition. They found that while antibiotics can help prevent infections in certain high-risk patients, routine use is often not recommended due to risks like antibiotic resistance. Their findings emphasize that doctors should tailor antibiotic treatment based on individual patient circumstances for better outcomes. Who this helps: This helps doctors and healthcare providers treating patients with acute pancreatitis.

PubMed

Drug-Induced Acute Pancreatitis in Adults: Focus on Antimicrobial and Antiviral Drugs, a Narrative Review.

2023

Antibiotics (Basel, Switzerland)

Del Gaudio A, Covello C, Di Vincenzo F, De Lucia SS, Mezza T +5 more

Plain English
This study examined how certain medications, especially antibiotics and antiviral drugs, can cause a severe inflammation of the pancreas called acute pancreatitis. The researchers found 51 types of drugs that are suspected to trigger this condition, with the strongest links to didanosine, protease inhibitors, and metronidazole. Understanding these drug associations is important because it can help develop better guidelines for preventing and managing this painful condition. Who this helps: This information benefits doctors and healthcare providers who prescribe these medications, as well as patients who may be at risk for acute pancreatitis.

PubMed

Alpha-Lipoic Acid and Glucose Metabolism: A Comprehensive Update on Biochemical and Therapeutic Features.

2022

Nutrients

Capece U, Moffa S, Improta I, Di Giuseppe G, Nista EC +6 more

Plain English
This study looked at alpha-lipoic acid (ALA), a natural compound that can help improve how the body handles sugar and insulin. The research highlighted that ALA benefits people with diabetic nerve damage by improving nerve function and reducing symptoms. However, it's important to note that some cases of insulin autoimmune syndrome (IAS) have occurred in people using ALA. Understanding how ALA affects glucose metabolism is crucial for safe and effective use in conditions like diabetes and obesity. Who this helps: Patients with diabetes and insulin resistance-related conditions.

PubMed

Clinical Implications ofAntibiotic Resistance in Italy: A Review of the Literature.

2022

Antibiotics (Basel, Switzerland)

Nista EC, Pellegrino A, Giuli L, Candelli M, Schepis T +4 more

Plain English
This study reviewed how antibiotics are working in Italy and found that there is a high level of antibiotic resistance, especially to clarithromycin, metronidazole, and levofloxacin. Specifically, the review highlighted that using a bismuth-based treatment can effectively eliminate infections, and naive patients saw good results with a clarithromycin quadruple therapy. Understanding these resistance patterns is important for doctors to choose the right antibiotic treatments for their patients. Who this helps: This helps doctors and patients dealing with antibiotic-resistant infections.

PubMed

Autoimmune Pancreatitis: From Pathogenesis to Treatment.

2022

International journal of molecular sciences

Nista EC, De Lucia SS, Manilla V, Schepis T, Pellegrino A +6 more

Plain English
This research paper looks at autoimmune pancreatitis (AIP), a rare disease that affects the pancreas. There are two types: type 1, linked to other diseases and related to a specific antibody, and type 2, which only affects the pancreas. Both types generally respond well to steroids, but the paper highlights the differences between them and explores new treatment options to improve diagnosis and reduce the chances of relapsing, including biologic drugs for patients who don't tolerate steroids well. Who this helps: This helps patients with autoimmune pancreatitis and their doctors by providing clearer treatment options.

PubMed

Effect of influenza vaccine on COVID-19 mortality: a retrospective study.

2021

Internal and emergency medicine

Candelli M, Pignataro G, Torelli E, Gullì A, Nista EC +8 more

Plain English
This study looked at whether getting a flu vaccine had an impact on death rates from COVID-19, especially among older patients. Out of 635 patients who tested positive for COVID-19, those who had received the flu vaccine were less likely to die within 60 days compared to those who hadn’t been vaccinated, showing a significant difference (p = 0.001). This matters because it suggests that flu vaccination might provide extra protection against severe outcomes from COVID-19, particularly for older adults. Who this helps: This helps older patients who are at higher risk of severe illness from COVID-19.

PubMed

Humoral Predictors of Malignancy in IPMN: A Review of the Literature.

2021

International journal of molecular sciences

Nista EC, Schepis T, Candelli M, Giuli L, Pignataro G +3 more

Plain English
This study reviewed research on pancreatic cysts called intraductal papillary mucinous neoplasms (IPMNs), which can lead to pancreatic cancer. It was found that certain markers and characteristics, like the size of cysts and levels of specific substances in the blood (like CA 19-9), can help predict when an IPMN might become cancerous. Using these markers could improve how doctors identify serious cases early on, as traditional imaging methods are often not sufficient. Who this helps: This helps doctors and patients at risk of pancreatic cancer by improving early detection.

PubMed

Microbiota in Pancreatic Diseases: A Review of the Literature.

2021

Journal of clinical medicine

Schepis T, De Lucia SS, Nista EC, Manilla V, Pignataro G +5 more

Plain English
This research looked at how the bacteria in our gut (the gut microbiota) affect pancreatic diseases. It found that changes in gut bacteria are linked to serious conditions like pancreatic cancer and pancreatitis, which are common and can lead to significant health problems. Altering gut bacteria might help improve treatment for these diseases, making this an important area for future healthcare strategies. Who this helps: This helps patients with pancreatic diseases and their doctors.

PubMed

Clinical Management of Infectious Diarrhea.

2020

Reviews on recent clinical trials

Siciliano V, Nista EC, Rosà T, Brigida M, Franceschi F

Plain English
This study focused on infectious diarrhea, which is a leading cause of illness and death worldwide, causing over 1.6 million deaths in 2016 alone. Researchers reviewed various causes and treatment options for infectious diarrhea, finding that many cases resolve on their own but some require specific diagnostic tests and targeted antibiotics, especially in vulnerable populations like the elderly or those with weakened immune systems. Understanding the appropriate management of this common issue is crucial for improving patient care and public health outcomes. Who this helps: Patients suffering from diarrhea, especially those with severe symptoms or underlying health conditions.

PubMed

Single-balloon push-and-pull enteroscopy system: does it work? A single-center, 3-year experience.

2011

Surgical endoscopy

Riccioni ME, Urgesi R, Cianci R, Spada C, Nista EC +1 more

Plain English
The study looked at a new procedure called single-balloon enteroscopy (SBE) to see how well it helps doctors diagnose and treat issues in the small intestine over three years. Researchers conducted 73 procedures and found that SBE effectively identified various conditions, diagnosing tumors in seven patients and helping treat issues in others, like bleeding and polyps, without any major complications. This matters because it shows SBE is a safe and valuable tool for dealing with hard-to-diagnose gastrointestinal problems. Who this helps: Patients with obscure gastrointestinal issues and their doctors.

PubMed

Obscure gastrointestinal bleeding as first symptom of eosinophilic jejunitis in a liver transplant recipient: diagnosis and treatment with single balloon enteroscopy.

2010

BMJ case reports

Urgesi R, Riccioni ME, Nista EC, Lionetti R, Tisone G +5 more

Plain English
The study focuses on a patient who received a liver transplant and experienced unexplained bleeding in the intestines. The doctors used a new technique called single balloon enteroscopy to diagnose the patient with eosinophilic enteritis, and after treatment, the patient was able to go home just three days later. This finding is important because it highlights a new method that can effectively diagnose and treat a disease that many medical professionals may not be familiar with, ensuring better care for similar patients. Who this helps: This helps patients with rare gastrointestinal conditions and their doctors.

PubMed

Regression of lactose malabsorption in coeliac patients after receiving a gluten-free diet.

2008

Scandinavian journal of gastroenterology

Ojetti V, Gabrielli M, Migneco A, Lauritano C, Zocco MA +4 more

Plain English
This study looked at how a gluten-free diet impacts lactose malabsorption in patients with silent coeliac disease. Out of 15 participants, only 1 showed improvement after 6 months, but after 12 months, 9 out of 14 had normalized breath test results, indicating less lactose malabsorption. This is significant because it suggests that a gluten-free diet can help many coeliac patients better digest lactose, potentially eliminating the need for a strict lactose-free diet. Who this helps: This research benefits coeliac patients who also struggle with lactose digestion.

PubMed

13C-methionine breath tests for mitochondrial liver function assessment.

2008

European review for medical and pharmacological sciences

Candelli M, Miele L, Armuzzi A, Nista EC, Pignataro G +7 more

Plain English
This study looked at two different types of breath tests using 13C-labeled methionine to check how well mitochondria in the liver are working. They found that one type of methionine (L-methionine-1-13COOH) was more effective than the other, allowing for a higher recovery of carbon dioxide in breath tests by 10.25% compared to 4.07%. This matters because it suggests that the L-methionine test might be a better way to assess liver function, especially after the body is under stress, like after drinking alcohol. Who this helps: This helps doctors and healthcare providers in better assessing liver function in patients.

PubMed

H pylori re-infection in type 1 diabetes: a 5 years follow-up.

2007

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Ojetti V, Migneco A, Nista EC, Gasbarrini G, Gasbarrini A +2 more

PubMed

Diagnostic and therapeutic impact of double-balloon enteroscopy (DBE) in a series of 100 patients with suspected small bowel diseases.

2007

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Cazzato IA, Cammarota G, Nista EC, Cesaro P, Sparano L +3 more

Plain English
This study looked at a new method called double-balloon enteroscopy (DBE) to examine and treat issues in the small intestine for 100 patients who might have small bowel diseases. The researchers found that DBE successfully diagnosed problems 69% of the time, with the most common issues being blood vessel abnormalities and ulcerations. This is important because in 65% of cases, the findings from DBE changed how patients were treated, meaning it can provide valuable information for better care. Who this helps: This helps patients with suspected small bowel diseases and their doctors.

PubMed

Role of probiotics in patients with Helicobacter pylori infection.

2007

Helicobacter

Franceschi F, Cazzato A, Nista EC, Scarpellini E, Roccarina D +3 more

Plain English
The study looked at how probiotics, which are beneficial bacteria, can help people infected with Helicobacter pylori, a germ linked to stomach issues. Researchers found that while probiotics might not replace standard treatments, they can make these treatments easier to tolerate, leading to better results for patients. For example, using probiotics alongside typical anti-H. pylori medications can reduce side effects and improve the chances of patients finishing their treatment. Who this helps: This helps patients with Helicobacter pylori infections.

PubMed

A case-control study comparing methylene blue directed biopsies and random biopsies for detecting pre-cancerous lesions in the follow-up of gastric cancer patients.

2007

European review for medical and pharmacological sciences

Ojetti V, Persiani R, Nista EC, Rausei S, Lecca G +6 more

Plain English
This study looked at how well methylene blue (MB) targeted biopsies compared to random biopsies in finding pre-cancerous changes in the stomach of patients who had surgery for gastric cancer. Among 30 patients, MB-guided biopsies found significant lesions in 13.3% (4 patients), while random biopsies mainly detected inflammation. This is important because using MB can improve the chances of detecting dangerous changes in the stomach lining, helping doctors to intervene earlier and more effectively. Who this helps: Patients who are recovering from gastric cancer surgeries.

PubMed

Gender affects 13C-ketoisocaproic acid breath test.

2007

European review for medical and pharmacological sciences

Candelli M, Armuzzi A, Miele L, Nista EC, Pignataro G +4 more

Plain English
This study looked at how gender impacts the way our bodies process a substance called 13C-ketoisocaproic acid, using a breath test to measure this in healthy people. Researchers found that, at rest, women showed a higher rate of processing this substance than men, but both genders had reduced processing after drinking ethanol. Understanding these differences is important because it could influence how treatments are designed for metabolic issues based on gender. Who this helps: Patients with metabolic disorders, doctors treating them, and researchers in the field.

PubMed

Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.

2006

The American journal of gastroenterology

Nista EC, Candelli M, Zocco MA, Cremonini F, Ojetti V +5 more

Plain English
This study looked at different treatments for people infected with Helicobacter pylori, a bacteria that can cause stomach problems. Researchers tested three groups of 300 patients: one received the standard treatment with clarithromycin and amoxicillin, another with clarithromycin and metronidazole, and the last with clarithromycin and levofloxacin. They found that the levofloxacin treatment had a higher success rate in eliminating the bacteria, achieving an 87% eradication compared to 75% and 72% for the other two treatments. Who this helps: This benefits patients suffering from Helicobacter pylori infections by offering a more effective treatment option.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.